Opthea LTD (OPTEY) SEC Filings — 2024
50 SEC filings for Opthea LTD (OPTEY) in 2024.
Filings
- Opthea to Present at J.P. Morgan Healthcare Conference — 6-K · Dec 19, 2024
- Opthea's Wet AMD Program Featured at FLORetina 2024 — 6-K · Nov 26, 2024
- Opthea to Present at Citi Global Healthcare Conference — 6-K · Nov 25, 2024
- Opthea Ltd Updates Corporate Presentation — 6-K · Nov 19, 2024
- Opthea Ltd Announces AGM Results & A$15.9M Tax Incentive — 6-K · Nov 15, 2024
- Opthea LTD SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Opthea's Wet AMD Program Featured at Ophthalmology Events — 6-K · Nov 12, 2024
- Opthea Ltd. to Present at November Investor Conferences — 6-K · Nov 4, 2024
- Opthea Ltd. Files Quarterly Report and Cashflow Update — 6-K · Nov 1, 2024
- Opthea Ltd Files October 2024 Corporate Presentation — 6-K · Oct 28, 2024
- Opthea Ltd Files Notice of Annual General Meeting — 6-K · Oct 16, 2024
- Opthea Presents Wet AMD Program at Innovate Retina — 6-K · Oct 10, 2024
- Opthea Appoints New CMO and CFO Ahead of Phase 3 Data — 6-K · Oct 8, 2024
- Opthea to Present at UBS Ophthalmology Day — 6-K · Sep 30, 2024
- Opthea Ltd Files 6-K, Includes Euretina Symposium Press Release — 6-K · Sep 26, 2024
- Opthea Joins S&P/ASX 300 Index — 6-K · Sep 23, 2024
- Opthea Ltd Files 20-F/A Amendment — 20-F/A · Sep 20, 2024
- Opthea to Present Sozinibercept Data at EURETINA Congress — 6-K · Sep 18, 2024
- Opthea to Present OCS-01 Data at EURETINA Congress — 6-K · Sep 10, 2024
- Opthea Ltd Files September 2024 Corporate Presentation — 6-K · Sep 9, 2024
- Opthea Ltd Announces Executive Leadership Changes — 6-K · Sep 5, 2024
- Opthea to Present at H.C. Wainwright & Cantor Conferences — 6-K · Sep 3, 2024
- Opthea Ltd Files 20-F for FY2024 — 20-F · Aug 30, 2024
- Opthea to Present at H.C. Wainwright Ophthalmology Conference — 6-K · Aug 8, 2024
- Opthea Adds Retina Experts to Medical Advisory Board — 6-K · Jul 17, 2024
- Opthea Raises A$55.9M in Retail Entitlement Offer — 6-K · Jul 15, 2024
- Opthea Research Highlights New Wet AMD Targets — 6-K · Jul 9, 2024
- Opthea LTD SC 13G/A Filing — SC 13G/A · Jul 3, 2024
- Opthea Opens A$55M Retail Offer — 6-K · Jun 20, 2024
- Opthea Raises A$171.5M in Placement and Entitlement Offer — 6-K · Jun 14, 2024
- Opthea Raises A$227.3M for Clinical Development — 6-K · Jun 12, 2024
- Opthea to Present Wet AMD Trial Data — 6-K · Jun 3, 2024
- Opthea Completes Enrollment in Wet AMD Phase 3 Trial — 6-K · May 28, 2024
- Opthea to Present Sozinibercept Data at Retina World Congress — 6-K · May 1, 2024
- Opthea Ltd Files April 2024 6-K Report — 6-K · Apr 30, 2024
- Opthea to Present at OIS Retina Innovation Summit — 6-K · Apr 25, 2024
- Opthea Appoints John Han as VP Medical Affairs — 6-K · Apr 9, 2024
- Opthea to Present at Needham Healthcare Conference — 6-K · Apr 5, 2024
- Opthea Ltd Appoints Sujal Shah to Board of Directors — 6-K · Apr 4, 2024
- Opthea Ltd. Holds KOL Event for Sozinibercept — 6-K · Apr 3, 2024
- Opthea to Host Opinion Leader Event on Sozinibercept — 6-K · Mar 19, 2024
- Opthea to Present at Leerink Biopharma Conference — 6-K · Mar 6, 2024
- Opthea Ltd Files March 2024 Corporate Presentation — 6-K · Mar 4, 2024
- Opthea Ltd. Reports Half-Year Financials and Updates — 6-K · Feb 29, 2024
- Opthea Appoints Dr. Arshad Khanani as Chief Medical Advisor — 6-K · Feb 20, 2024
- Opthea LTD SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Opthea LTD SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Opthea Completes Enrollment in First Pivotal Sozinibercept Trial — 6-K · Feb 14, 2024
- Opthea Bolsters Clinical & Regulatory Teams with Key Hires — 6-K · Feb 1, 2024
- Opthea Presents Sozinibercept for Wet AMD at J.P. Morgan Conference — 6-K · Jan 11, 2024